Klinik und Poliklinik für Dermatologie und Venerologie

You are here:
Informationen

Publikationen

  • Kreuter M et al; Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network;
    European Respiratory Journal 2019 54: OA3595; DOI: 10.1183/13993003.congress-2019.OA3595
  • Kreuter M et al; Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis; Rheumatology (Oxford). 2023 Sep 1;62(9):3067-3074. doi: 10.1093/rheumatology/kead023.
  • N. Blank et al.;Autologous hematopoietic stem cell transplantation improves long-term survival data from a national registry, Arthritis Res. Ther.,2022; 24: 258 doi: 10.1186
  • P. Moinzadeh et al.; Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival in over 5,000 patients, Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.08.013.
  • Hunzelmann N, Krieg T; Kooperationspartner der DNSS., The German network for systemic sclerosis (DNSS): current data on dianostics and therapy; Hautarzt. 2012 Apr;63 Suppl 1:71-5. doi: 10.1007/s00105-011-2300-0. Review. German.
  • Müller-Ladner U.; Systemic sclerosis; Internist (Berl). 2008 Mar;49(3):278-85. doi: 10.1007/s00108-007-2011-x. Review. German.
  • Hunzelmann N, Genth E, Krieg T, Meurer M, Melchers I, Moinzadeh P, Pfeiffer C, Riemekasten G, Schulze-Lohoff E, Sunderkoetter C, Müller-Ladner U; German Network for Systemic Sclerosis, Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS); Z Rheumatol. 2008 Jul;67(4):334-6, 337-40. doi: 10.1007/s00393-008-0291-8. German.
  • Hunzelmann N, Genth E, Krieg T, and all participating DNSS centers. Empfehlungen des Deutschen Netzwerkes für Systemische Sklerodermie für die organspezifische Diagnostik von Patienten mit Systemischer Sklerodermie; Z Rheumatol. 2008 Jul;67(4):334-6, 337-40.
  • Herrgott I, Riemekasten G, Hunzelmann N, Sunderkötter C.; Management of cutaneous vascular complications in systemic scleroderma: experience from the German Network; Rheumatol Int. 2008 Aug;28(10):1023-9. doi: 10.1007/s00296-008-0556-1. Epub 2008 Mar 5.
  • Hunzelmann N, Genth E, Krieg T, and all participating DNSS centers. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford), 2008 Aug;47(8):1185-92.
  • Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C; DNSS centers, Riemekasten G.; Skin sclerosis is only of limited value to identify SSc patients with severe manifestations–an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register; Rheumatology (Oxford). 2009 Jan;48(1):70-3. doi: 10.1093/rheumatology/ken408.
  • Hunzelmann N, Moinzadeh P, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Olski TM, Pfeiffer C, Riemekasten G, Schulze-Lohoff E, Sunderkoetter C, Weber M; German Network for Systemic Scleroderma Centers., High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy; Arthritis Res Ther. 2009;11(2):R30. doi: 10.1186/ar2634. Epub 2009 Mar 4.
  • Sunderkötter C, Herrgott I, Brückner C, Moinzadeh P, Pfeiffer C, Gerss J, Hunzelmann N, Böhm M, Krieg T, Müller-Ladner U, Genth E, Schulze-Lohoff E, Meurer M, Melchers I, Riemekasten G; DNSS Centers., Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors; Br J Dermatol. 2009 Apr;160(4):835-43. doi: 10.1111/j.1365-2133.2008.09004.x. Epub 2009 Jan 13.
  • Mierau R, Moinzadeh P, Riemekasten G, and all participating DNSS centers. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical Features; Arthritis Rhes Ther Oct 21, 13(5):R172 (2011)
  • Fransen J, Popa-Diaconu D, Hesselstrand R, et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres: Ann Rheum Dis. 2011 Oct;70(10):1788-92.
  • Hunzelmann N, Krieg T; Kooperationspartner der DNSS., The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy; Hautarzt. 2012 Apr;63 Suppl 1:71-5. doi: 10.1007/s00105-011-2300-0. Review. German.
  • Schmeiser T, Saar P, Jin D, Noethe M, Müller A, Soydan N, Hardt PD, Jaeger C, Distler O, Roeb E, Bretzel RG, Müller-Ladner U., Profile of gastrointestinal involvement in patients with systemic sclerosis; Rheumatol Int. 2012 Aug;32(8):2471-8. doi: 10.1007/s00296-011-1988-6. Epub 2011 Jul 19.
  • Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N; all participating DNSS centers., Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis; Ann Rheum Dis. 2015 Apr;74(4):730-7. doi: 10.1136/annrheumdis-2013-204487. Epub 2014 Jan 3.
  • Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, and all participating DNSS centers. Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients; J Rheumatol. 2016 Jan;43(1):66-74.
  • Hunzelmann N, Riemekasten G, Becker M, Moinzadeh P, Kreuter A, et al. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies; Br J Dermatol. 2016 Jun;174(6):1384-7.
  • Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, Siegert E, Pfeiffer C, Schmalzing M, Zeidler G, Schmeiser T, Worm M, Guenther C, Susok L, Kreuter A, Sunderkoetter C, Juche A, Aberer E, Gaebelein-Wissing N, Ramming A, Kuhr K, Hunzelmann N.; Large variability of frequency and type of physical therapy in patients of the German Network for Systemic Sclerosis;  Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23998.
  • Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, Schmalzing M, Worm M, Schmeiser T, Günther C, Aberer E, Susok L, Riemekasten G, Kreuter A, Zeidler G, Juche A, Hadjiski D, Müller-Ladner U, Gaebelein-Wissing N, Distler JHW, Sárdy M, Krieg T, Hunzelmann N.; Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication; J Rheumatol. 2019 Apr 1. pii: jrheum.180582. doi: 10.3899/jrheum.180582.
  • Juche A, Siegert E, Mueller-Ladner U, Riemekasten G, Günther C, Kötter I, Henes J, Blank N, Voll RE, Ehrchen J, Schmalzing M, Susok L, Schmeiser T, Sunderkoetter C, Distler J, Worm M, Kreuter A, Horváth ON, Schön MP, Korsten P, Zeidler G, Pfeiffer C, Krieg T, Hunzelmann N, Moinzadeh P. Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany.Z Rheumatol. 2020 Feb 10. doi: 10.1007/s00393-019-00743-9. [Epub ahead of print] German.
  • Moinzadeh P, Kuhr K, Siegert E, Mueller-Ladner U, Riemekasten G, Günther C, Kötter I, Henes J, Blank N, Zeidler G, Pfeiffer C, Juche A, Jandova I, Ehrchen J, Schmalzing M, Susok L, Schmeiser T, Sunderkoetter C, Distler JHW, Worm M, Kreuter A, Krieg T, Hunzelmann N. Older age onset of systemic sclerosis – accelerated disease progression in all disease subsets.Rheumatology (Oxford). 2020 Apr 24. pii: keaa127. doi: 10.1093/rheumatology/keaa127. [Epub ahead of print]